Anxiety disorders — generalized anxiety disorder, panic disorder, social anxiety, and specific phobias — co-occur with substance use disorder more often than in the general population.
Substance use that started as a way to manage symptoms eventually creates its own problem. These are the patterns clinicians look for in co-occurring anxiety and addiction:
Integrated treatment addresses both the anxiety driving use and the substance use that is now amplifying anxiety. The clinical sequence typically involves medical stabilization (especially critical for benzodiazepine taper), structured behavioral therapy targeting both conditions, and, where a prescriber indicates it, mental health medication that carries no dependence risk. Benzodiazepine prescribing for someone with active substance use is generally avoided.
DSM-5: F41.1, F41.0, F40
Different condition pairs respond to different therapies. The modalities below have the strongest evidence base for co-occurring anxiety and addiction.
Kentucky Medicaid plans typically cover integrated treatment for anxiety co-occurring with SUD, including mental health evaluation, medication management with non-addictive alternatives to benzodiazepines, and evidence-based therapies. Pharmacy benefits cover SSRIs, SNRIs, buspirone, and other non-controlled anxiety medications.
Coverage is determined by medical necessity. Call admissions and we'll verify your specific plan as part of the call.
Depression and substance use disorder co-occur at very high rates: many adults with major depressive disorder also experience a substance use disorder, and the relationship runs both ways — depression increases SUD risk, and chronic substance use worsens depression.
Read more →Post-traumatic stress disorder (PTSD) and substance use disorder co-occur at exceptionally high rates: a large share of people in substance use treatment also meet criteria for PTSD.
Read more →Admissions answers 24/7. Golden Grove will accept Kentucky Medicaid. Coverage check happens on the call.